Use of Individual PK-guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Sunitinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacogenomic
- 07 Oct 2011 Actual initiation date (Mar 2011) added as reported by ClinicalTrials.gov.
- 07 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Feb 2011 New trial record